These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27711164)

  • 1. Partner Disclosure and Early CD4 Response among HIV-Infected Adults Initiating Antiretroviral Treatment in Nairobi Kenya.
    Trinh TT; Yatich N; Ngomoa R; McGrath CJ; Richardson BA; Sakr SR; Langat A; John-Stewart GC; Chung MH
    PLoS One; 2016; 11(10):e0163594. PubMed ID: 27711164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study.
    Bahemana E; Esber A; Dear N; Ganesan K; Parikh A; Reed D; Maganga L; Khamadi S; Mizinduko M; Lwilla A; Mkondoo D; Mwaisanga G; Somi N; Owouth J; Maswai J; Kiweewa F; Iroezindu M; Ake JA; Crowell TA; Valcour VG; Polyak CS;
    AIDS Res Ther; 2020 Nov; 17(1):66. PubMed ID: 33183355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with pre-ART loss-to-follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study.
    Evangeli M; Newell ML; McGrath N
    BMC Public Health; 2016 Apr; 16():358. PubMed ID: 27117271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disclosure of HIV seropositive status to sexual partners and its associated factors among patients attending antiretroviral treatment clinic follow up at Mekelle Hospital, Ethiopia: a cross sectional study.
    Genet M; Sebsibie G; Gultie T
    BMC Res Notes; 2015 Mar; 8():109. PubMed ID: 25889779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol use and immune reconstitution among HIV-infected patients on antiretroviral therapy in Nairobi, Kenya.
    Cagle A; McGrath C; Richardson BA; Donovan D; Sakr S; Yatich N; Ngomoa R; Chepngeno Langat A; John-Stewart G; Chung MH
    AIDS Care; 2017 Sep; 29(9):1192-1197. PubMed ID: 28132519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, patterns, and correlates of HIV disclosure among TB-HIV patients initiating antiretroviral therapy in Lesotho.
    Hayes-Larson E; Hirsch-Moverman Y; Saito S; Frederix K; Pitt B; Maama BL; Howard AA
    AIDS Care; 2017 Aug; 29(8):978-984. PubMed ID: 28100068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis disclosure to adolescents living with HIV in rural Kenya improves antiretroviral therapy adherence and immunologic outcomes: A retrospective cohort study.
    Montalto GJ; Sawe FK; Miruka A; Maswai J; Kiptoo I; Aoko A; Oreyo C; Obiero E; Korir S; Bii SK; Song KX; Kunz AN
    PLoS One; 2017; 12(10):e0183180. PubMed ID: 28991913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries.
    Eduardo E; Lamb MR; Kandula S; Howard A; Mugisha V; Kimanga D; Kilama B; El-Sadr W; Elul B
    PLoS One; 2014; 9(7):e103864. PubMed ID: 25075743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV serostatus disclosure in the treatment cascade: evidence from Northern Tanzania.
    Ostermann J; Pence B; Whetten K; Yao J; Itemba D; Maro V; Reddy E; Thielman N
    AIDS Care; 2015; 27 Suppl 1(sup1):59-64. PubMed ID: 26616126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does sexual behaviour of people with HIV reflect antiretroviral therapy as a preventive strategy? A cross-sectional study among outpatients in Kenya.
    Nkhoma K; Ahmed A; Alli Z; Sherr L; Harding R
    BMC Public Health; 2019 Sep; 19(1):1254. PubMed ID: 31510974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling adverse treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics in Lusaka.
    Fwemba I; Musonda P
    Public Health; 2017 Jun; 147():8-14. PubMed ID: 28404502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the magnitude and associated factors of immunological failure among adult and adolescent HIV-infected patients in St. Luke and Tulubolo Hospital, Oromia Region, Ethiopia.
    Bayou B; Sisay A; Kumie A
    Pan Afr Med J; 2015; 21():291. PubMed ID: 26587140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of disclosure on adherence to antiretroviral therapy among adults living with HIV in Ethiopia: a systematic review and meta-analysis.
    Dessie G; Wagnew F; Mulugeta H; Amare D; Jara D; Leshargie CT; Negesse A; Rayasam S; Burrowes S
    BMC Infect Dis; 2019 Jun; 19(1):528. PubMed ID: 31208346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in clinical characteristics and outcomes of Pre-ART care at a large HIV clinic in Nairobi, Kenya: a retrospective cohort study.
    Mecha JO; Kubo EN; Nganga LW; Muiruri PN; Njagi LN; Mutisya IN; Odionyi JJ; Ilovi SC; Wambui M; Githu C; Ngethe R; Obimbo EM; Ngumi ZW
    AIDS Res Ther; 2016; 13():38. PubMed ID: 27895697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
    Izudi J; Alioni S; Kerukadho E; Ndungutse D
    BMC Infect Dis; 2016 Oct; 16(1):614. PubMed ID: 27793124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV status disclosure to sexual partners, among people living with HIV and AIDS on antiretroviral therapy at Sokodé regional hospital, Togo.
    Yaya I; Saka B; Landoh DE; Patchali PM; Patassi AA; Aboubakari AS; Makawa MS; N'Dri MK; Senanou S; Lamboni B; Idrissou D; Salaka KT; Pitché P
    PLoS One; 2015; 10(2):e0118157. PubMed ID: 25658105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safer sexual behaviors after 12 months of antiretroviral treatment in Mombasa, Kenya: a prospective cohort.
    Luchters S; Sarna A; Geibel S; Chersich MF; Munyao P; Kaai S; Mandaliya KN; Shikely KS; Rutenberg N; Temmerman M
    AIDS Patient Care STDS; 2008 Jul; 22(7):587-94. PubMed ID: 18601582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
    Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
    J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.